| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
89125.1 |
nM |
None |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
63000.0 |
nM |
10.1039/C0MD00207K |
| Bacteria |
Cell membrane |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c01604 |
| Bos taurus |
NADH-ubiquinone oxidoreductase chain 1 |
IC50 |
52480.75 |
nM |
10.1016/0005-2728(95)00131-x |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Cavia porcellus |
Dose |
0.018 |
uM kg-1 |
10.1021/jm960512h |
| Cavia porcellus |
Cavia porcellus |
EC50 |
260.0 |
nM |
10.1021/jm00068a014 |
| Cavia porcellus |
Cavia porcellus |
EC50 |
260.0 |
nM |
10.1021/jm00068a015 |
| Cavia porcellus |
Cavia porcellus |
EC50 |
260.0 |
nM |
10.1021/jm00068a016 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Diaprepes abbreviatus |
Diaprepes abbreviatus |
Activity |
1.02 |
cm2 |
10.1002/ps.2125 |
| Electrophorus electricus |
Acetylcholinesterase |
Activity |
11.0 |
% |
10.1021/acs.jmedchem.0c01775 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
nan |
None |
10.1007/s00044-008-9122-3 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
-6.53 |
% |
10.1016/j.bmc.2012.09.040 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
11.4 |
% |
10.1007/s00044-008-9122-3 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
nan |
% |
10.1007/s00044-008-9122-3 |
| Equus caballus |
Cholinesterase |
Inhibition |
6.29 |
% |
10.1016/j.bmc.2012.09.040 |
| Equus caballus |
Cholinesterase |
Inhibition |
nan |
% |
10.1007/s00044-008-9122-3 |
| Escherichia coli |
Escherichia coli |
MIC |
50.0 |
ug.mL-1 |
10.1021/acs.jmedchem.2c01604 |
| Homo sapiens |
A2058 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2019.05.020 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
200000.0 |
nM |
10.1021/acs.jmedchem.0c01775 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
Activity |
nan |
None |
10.1016/j.bmcl.2010.02.059 |
| Homo sapiens |
Androgen Receptor |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Arachidonate 5-lipoxygenase |
IC50 |
56000.0 |
nM |
10.1016/j.bmc.2019.06.040 |
| Homo sapiens |
ASPC1 |
Inhibition |
73.0 |
% |
10.1016/j.ejmech.2019.07.034 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Beta-secretase 1 |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c01775 |
| Homo sapiens |
BGC-823 |
IC50 |
4659.0 |
nM |
10.1016/j.ejmech.2021.113254 |
| Homo sapiens |
Bile salt export pump |
IC50 |
10000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Butyrylcholinesterase |
Inhibition |
20.0 |
% |
10.1021/acs.jmedchem.0c01775 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
5600.0 |
nM |
10.1021/acs.jmedchem.0c00530 |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
10000.0 |
nM |
10.1021/jm900130m |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB2 receptor |
Ki |
10000.0 |
nM |
10.1021/jm900130m |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cell line |
ED50 |
3.0 |
ug |
10.1021/jm0495071 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
1551.0 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
3800.0 |
nM |
10.1021/np049655u |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
3200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
3000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
mechanism based inhibition |
nan |
None |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
23.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
HCT-116 |
IC50 |
40160.0 |
nM |
10.1021/acsmedchemlett.1c00304 |
| Homo sapiens |
HEK-293T |
Activity |
nan |
None |
10.1016/j.bmc.2019.05.020 |
| Homo sapiens |
HeLa |
IC50 |
50000.0 |
nM |
10.1016/j.bmc.2018.04.031 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-19.65 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-2.58 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
K562 |
IC50 |
49410.0 |
nM |
10.1016/j.bmc.2018.04.031 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Lysine-specific histone demethylase 1 |
IC50 |
600.0 |
nM |
10.1016/j.ejmech.2021.113254 |
| Homo sapiens |
Lysine-specific histone demethylase 1 |
IC50 |
600.0 |
nM |
10.1016/j.ejmech.2022.114143 |
| Homo sapiens |
Lysine-specific histone demethylase 1 |
IC50 |
600.0 |
nM |
10.1016/j.ejmech.2022.114564 |
| Homo sapiens |
Lysine-specific histone demethylase 1 |
IC50 |
600.0 |
nM |
10.1021/acs.jmedchem.0c02176 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
IC50 |
49970.0 |
nM |
10.1016/j.bmc.2018.04.031 |
| Homo sapiens |
MCF7 |
IC50 |
100000.0 |
nM |
10.1021/acs.jmedchem.0c01679 |
| Homo sapiens |
MDA-MB-231 |
Activity |
281.3 |
mm3 |
10.1021/acs.jmedchem.0c00530 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
120000.0 |
nM |
10.1021/acs.jmedchem.0c00530 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
158489.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NCI-H460 |
Activity |
7.17 |
% |
10.1021/acsmedchemlett.1c00304 |
| Homo sapiens |
NCI-H460 |
Activity |
7.25 |
% |
10.1021/acsmedchemlett.1c00304 |
| Homo sapiens |
NCI-H460 |
IC50 |
30660.0 |
nM |
10.1021/acsmedchemlett.1c00304 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
10870.7 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
30637.9 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
42163.2 |
nM |
None |
| Homo sapiens |
Nuclear receptor ROR-gamma |
Potency |
33491.5 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SH-SY5Y |
EC50 |
14020.0 |
nM |
10.1016/j.ejmech.2019.111695 |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-MEL-25 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2019.05.020 |
| Homo sapiens |
SK-OV-3 |
IC50 |
22030.0 |
nM |
10.1021/acsmedchemlett.1c00304 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
T47D |
IC50 |
100000.0 |
nM |
10.1021/acs.jmedchem.0c01679 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Transient receptor potential cation channel subfamily M member 8 |
IC50 |
1000.0 |
nM |
10.1021/acs.jmedchem.6b00305 |
| Homo sapiens |
Transient receptor potential cation channel subfamily V member 6 |
Activity |
nan |
None |
10.1016/j.bmc.2019.05.020 |
| Homo sapiens |
Transient receptor potential cation channel subfamily V member 6 |
Inhibition |
nan |
% |
10.1039/d0md00145g |
| Homo sapiens |
Transthyretin |
Inhibition |
20.0 |
% |
10.1021/jm500997m |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29855.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-tRNA synthetase |
Ki |
42000.0 |
nM |
10.1016/S0960-894X(97)00434-4 |
| Homo sapiens |
U-87 MG |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2019.05.020 |
| Homo sapiens |
Vanilloid receptor |
Activity |
0.01 |
uM |
10.1038/nchembio0705-85 |
| Homo sapiens |
Vanilloid receptor |
Activity |
nan |
None |
10.1016/j.bmc.2019.03.025 |
| Homo sapiens |
Vanilloid receptor |
Activity |
nan |
None |
10.1016/j.bmc.2019.05.020 |
| Homo sapiens |
Vanilloid receptor |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00469 |
| Homo sapiens |
Vanilloid receptor |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b00156 |
| Homo sapiens |
Vanilloid receptor |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01046 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
2.512 |
nM |
10.1016/j.bmc.2010.03.013 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
3.9 |
nM |
10.1016/j.bmcl.2011.12.113 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
5.3 |
nM |
10.1016/j.bmcl.2015.01.039 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
5.3 |
nM |
10.1021/acs.jnatprod.0c00639 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
7.2 |
nM |
10.1016/j.bmc.2019.05.020 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
19.95 |
nM |
10.1021/jm020844o |
| Homo sapiens |
Vanilloid receptor |
EC50 |
20.0 |
nM |
10.1021/jm900130m |
| Homo sapiens |
Vanilloid receptor |
EC50 |
25.9 |
nM |
10.1021/acs.jmedchem.9b01046 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
29.0 |
nM |
10.1021/acs.jmedchem.2c00469 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
40.0 |
nM |
10.1016/j.bmcl.2006.09.077 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
40.0 |
nM |
10.1016/j.bmcl.2009.11.035 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
44.8 |
nM |
10.1021/acs.jmedchem.0c00982 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
870.0 |
nM |
10.1021/acs.jmedchem.8b00156 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
870.96 |
nM |
10.1021/acs.jmedchem.8b00156 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
1000.0 |
nM |
10.1021/acs.jmedchem.8b00109 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
30200.0 |
nM |
10.1021/acs.jmedchem.0c00530 |
| Homo sapiens |
Vanilloid receptor |
Efficacy |
78.6 |
% |
10.1016/j.bmcl.2011.12.113 |
| Homo sapiens |
Vanilloid receptor |
Efficacy |
78.6 |
% |
10.1016/j.bmcl.2015.01.039 |
| Homo sapiens |
Vanilloid receptor |
Efficacy |
79.0 |
% |
10.1021/acs.jnatprod.0c00639 |
| Homo sapiens |
Vanilloid receptor |
Efficacy |
100.0 |
% |
10.1021/acs.jmedchem.2c00469 |
| Homo sapiens |
Vanilloid receptor |
Emax |
97.0 |
% |
10.1016/j.bmc.2010.03.013 |
| Homo sapiens |
Vanilloid receptor |
FC |
1.13 |
None |
10.1021/acs.jmedchem.8b00156 |
| Homo sapiens |
Vanilloid receptor |
FC |
2.81 |
None |
10.1021/acs.jmedchem.8b00156 |
| Homo sapiens |
Vanilloid receptor |
Hill coefficient |
2.0 |
None |
10.1021/jm960063l |
| Homo sapiens |
Vanilloid receptor |
IC50 |
8.0 |
nM |
10.1016/j.bmcl.2015.01.039 |
| Homo sapiens |
Vanilloid receptor |
IC50 |
8.0 |
nM |
10.1021/acs.jnatprod.0c00639 |
| Homo sapiens |
Vanilloid receptor |
Inhibition |
96.74 |
% |
10.1016/j.ejmech.2022.114413 |
| Homo sapiens |
Vanilloid receptor |
Ki |
6.0 |
nM |
10.1016/j.bmcl.2010.09.023 |
| Homo sapiens |
Vanilloid receptor |
Ki |
1070.0 |
nM |
10.1021/acs.jmedchem.9b01046 |
| Homo sapiens |
Vanilloid receptor |
Ki |
1140.0 |
nM |
10.1021/acs.jmedchem.7b00859 |
| Homo sapiens |
Vanilloid receptor |
Ki |
2530.0 |
nM |
10.1021/acs.jmedchem.7b00859 |
| Homo sapiens |
Vanilloid receptor |
Potency |
6.5 |
nM |
None |
| Homo sapiens |
Vanilloid receptor |
Potency |
32.1 |
nM |
None |
| Homo sapiens |
Vanilloid receptor |
Potency |
91.2 |
nM |
None |
| Homo sapiens |
Vanilloid receptor |
Ratio |
1.885 |
None |
10.1016/j.bmc.2018.04.031 |
| Homo sapiens |
Vanilloid receptor |
Ratio |
6.09 |
None |
10.1021/acs.jmedchem.8b00156 |
| Homo sapiens |
Vanilloid receptor |
Response |
65.4 |
% |
10.1021/jm020844o |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv1.1 |
IC50 |
29000.0 |
nM |
10.1021/acs.jmedchem.6b01262 |
| Mus musculus |
B16-F10 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2019.05.020 |
| Mus musculus |
Mus musculus |
Activity |
0.099 |
mg/ml |
10.1016/j.ejmech.2009.02.017 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmc.2018.04.031 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmc.2019.05.020 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01046 |
| Mus musculus |
Mus musculus |
ED50 |
5.72 |
umol.kg-1 |
10.1021/jm960512h |
| Mus musculus |
Mus musculus |
ED50 |
10.3 |
umol.kg-1 |
10.1021/jm960512h |
| Mus musculus |
Mus musculus |
ED50 |
15.0 |
umol.kg-1 |
10.1021/jm00068a014 |
| Mus musculus |
Mus musculus |
ED50 |
15.0 |
umol.kg-1 |
10.1021/jm00068a015 |
| Mus musculus |
Mus musculus |
ED50 |
15.0 |
umol.kg-1 |
10.1021/jm00068a016 |
| Mus musculus |
Mus musculus |
ED50 |
962.0 |
umol.kg-1 |
10.1021/jm960512h |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Mus musculus |
Transient receptor potential cation channel subfamily M member 8 |
IC50 |
28000.0 |
nM |
10.1021/np400885u |
| Mus musculus |
Transient receptor potential cation channel subfamily M member 8 |
IC50 |
100000.0 |
nM |
10.1021/np400885u |
| Mus musculus |
Transient receptor potential cation channel subfamily M member 8 |
Inhibition |
nan |
% |
10.1021/np400885u |
| Mus musculus |
Transient receptor potential cation channel subfamily V member 1 |
Activity |
nan |
None |
10.1016/j.bmcl.2016.12.002 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
19011.5 |
nM |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
C6 |
Activity |
20.0 |
% |
10.1021/acs.jmedchem.0c01679 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
21999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Hormone-sensitive lipase |
Inhibition |
33.0 |
% |
10.1021/jm800718k |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
2818.4 |
nM |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Lysophosphatidic acid receptor Edg-2 |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01287 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
9074.3 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
314.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
316.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
391.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
433.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
40.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
44.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
50.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
52.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
71.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
75.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
83.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
93.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BP |
-49.5 |
mmHg |
10.1021/jm00033a011 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
173.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
180.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
183.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
104.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
105.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
107.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
570.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
620.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
680.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
756.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
166.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
217.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
554.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
629.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
25330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
25670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.1 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
DOSE |
0.001 |
mg.kg-1 |
10.1021/jm00033a011 |
| Rattus norvegicus |
Rattus norvegicus |
EC50 |
300.0 |
nM |
10.1021/jm00039a006 |
| Rattus norvegicus |
Rattus norvegicus |
EC50 |
300.0 |
nM |
10.1021/jm00068a014 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
117.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
118.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
231.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1416.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1530.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1770.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1776.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.03 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.53 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.43 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.97 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
125300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
127000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
129700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
133300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LD50 |
161.2 |
mg.kg-1 |
10.1016/j.bmc.2018.04.031 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
115.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
119.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
121.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
471.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
7477.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12147.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12823.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
14371.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
89.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
92.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
92.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.37 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.4 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.6 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.13 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
376300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
379000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
379300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
381300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.27 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.03 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.17 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.63 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
58.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
60.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
176.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
374.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
5.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
6.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
7.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
496.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
735.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1135.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1243.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
116.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
124.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
126.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
131.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1256670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1274000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1334000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1342330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.75 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.84 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.01 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.02 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
59000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
60300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
62000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5280000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5310000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5550000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5710000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.33 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
145.1 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
145.37 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.17 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
147.2 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
11.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
15.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
8030.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
13570.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
13970.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
16000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Transient receptor potential cation channel subfamily A member 1 |
Activity |
nan |
None |
10.1016/j.bmcl.2017.05.025 |
| Rattus norvegicus |
Transient receptor potential cation channel subfamily A member 1 |
EC50 |
nan |
None |
10.1016/j.bmcl.2015.01.039 |
| Rattus norvegicus |
Transient receptor potential cation channel subfamily A member 1 |
Efficacy |
100.0 |
% |
10.1016/j.bmcl.2011.12.113 |
| Rattus norvegicus |
Vanilloid receptor |
Activity |
-497.0 |
pA/pF |
10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus |
Vanilloid receptor |
Activity |
nan |
None |
10.1016/j.bmc.2008.11.085 |
| Rattus norvegicus |
Vanilloid receptor |
Activity |
nan |
None |
10.1016/j.bmcl.2013.12.061 |
| Rattus norvegicus |
Vanilloid receptor |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01046 |
| Rattus norvegicus |
Vanilloid receptor |
Activity |
nan |
None |
10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
30.0 |
nM |
10.1016/j.bmcl.2003.11.019 |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
44.8 |
nM |
10.1016/j.bmc.2008.11.085 |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
44.8 |
nM |
10.1021/acs.jmedchem.9b01046 |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
44.8 |
nM |
10.1021/jm030089u |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
300.0 |
nM |
10.1021/jm00068a015 |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
300.0 |
nM |
10.1021/jm00068a016 |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
300.0 |
nM |
10.1021/jm960139d |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
300.0 |
nM |
10.1021/jm960512h |
| Rattus norvegicus |
Vanilloid receptor |
EC50 |
2320.0 |
nM |
10.1021/acsmedchemlett.8b00618 |
| Rattus norvegicus |
Vanilloid receptor |
IC50 |
19.0 |
nM |
10.1016/j.bmcl.2010.09.023 |
| Rattus norvegicus |
Vanilloid receptor |
IC50 |
nan |
nM |
10.1016/j.bmcl.2003.11.019 |
| Rattus norvegicus |
Vanilloid receptor |
Ki |
1700.0 |
nM |
10.1021/jm030089u |
| Rattus norvegicus |
Vanilloid receptor |
Ki |
1800.0 |
nM |
10.1021/jm030089u |
| Rattus norvegicus |
Vanilloid receptor |
Ki |
1808.0 |
nM |
10.1016/j.bmc.2008.11.085 |
| Rattus norvegicus |
Vanilloid receptor |
Ki |
1810.0 |
nM |
10.1021/acs.jmedchem.9b01046 |
| Rattus norvegicus |
Vanilloid receptor |
Ki |
2000.0 |
nM |
10.1021/jm960063l |
| Rattus norvegicus |
Vanilloid receptor |
Ki |
2000.0 |
nM |
10.1021/jm960139d |
| Rattus norvegicus |
Vanilloid receptor |
NE |
nan |
None |
10.1021/jm030089u |
| Schistocerca americana |
Schistocerca americana |
Activity |
1.08 |
cm2 |
10.1002/ps.2125 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
5.3 |
% |
10.1021/acs.jnatprod.2c00843 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
5.6 |
% |
10.1021/acs.jnatprod.2c00843 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
26.63 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1538 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
1.12 |
% |
10.21203/rs.3.rs-23951/v1 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1021/acs.jmedchem.7b00215 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
50.0 |
ug.mL-1 |
10.1016/j.ejmech.2020.112352 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
50.0 |
ug.mL-1 |
10.1021/acs.jmedchem.2c01604 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
756.9 |
nM |
None |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00469 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01046 |
| None |
ADMET |
CL |
212.0 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.2c00469 |
| None |
ADMET |
Drugabsorption |
nan |
None |
10.1021/acs.jmedchem.9b01046 |
| None |
ADMET |
Drug uptake |
nan |
None |
10.1021/acs.jmedchem.9b01046 |
| None |
ADMET |
LD50 |
6.5 |
mg.kg-1 |
10.1021/acs.jmedchem.2c00469 |
| None |
ADMET |
LD50 |
7.5 |
mg.kg-1 |
10.1021/acs.jmedchem.9b01046 |
| None |
ADMET |
LD50 |
118.8 |
mg.kg-1 |
10.1021/acs.jmedchem.9b01046 |
| None |
ADMET |
permeability |
10.3 |
10^-6 cm/s |
10.1021/acs.jmedchem.0c01775 |
| None |
ADMET |
Stability |
96.0 |
% |
10.1021/acs.jmedchem.8b00109 |
| None |
ADMET |
Stability |
99.0 |
% |
10.1021/acs.jmedchem.8b00109 |
| None |
ADMET |
Stability |
99.3 |
% |
10.1021/acs.jmedchem.8b00109 |
| None |
ADMET |
Stability |
100.0 |
% |
10.1021/acs.jmedchem.8b00109 |
| None |
Hepatotoxicity |
DILI positive/negative |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Lipid bilayer |
Activity |
18.0 |
uM |
10.1021/acs.jmedchem.6b01026 |
| None |
Lipid bilayer |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00958 |
| None |
Lipid bilayer |
deltaG |
-0.6 |
kcal/mol |
10.1021/acs.jmedchem.0c00958 |
| None |
Lipid bilayer |
deltaG |
-0.5 |
kcal/mol |
10.1021/acs.jmedchem.0c00958 |
| None |
Molecular identity unknown |
Potency |
25118.9 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
39810.7 |
nM |
None |
| None |
No relevant target |
EC50 |
nan |
None |
10.1021/acs.jmedchem.8b00156 |
| None |
No relevant target |
IC50 |
50300.0 |
nM |
10.1021/acs.jmedchem.0c01775 |
| None |
No relevant target |
Stability |
nan |
% |
10.1016/j.bmc.2019.03.025 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00469 |
| None |
Unchecked |
EC50 |
16370.0 |
nM |
10.1016/j.ejmech.2019.111695 |
| None |
Unchecked |
HC50 |
200.0 |
ug ml-1 |
10.1021/acs.jmedchem.2c01604 |
| None |
Unchecked |
IC50 |
16982.44 |
nM |
10.1016/0005-2728(95)00131-x |
| None |
Unchecked |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2019.05.020 |
| None |
Unchecked |
IC50 |
134896.29 |
nM |
10.1016/0005-2728(95)00131-x |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
20.0 |
% |
10.1016/0005-2728(95)00131-x |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/0005-2728(95)00131-x |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
1412.5 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
25118.9 |
nM |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Potency |
39810.7 |
nM |
None |
| None |
Unchecked |
Potency |
44668.4 |
nM |
None |